IFG
SLS icon

Independent Financial Group’s SELLAS Life Sciences SLS Stock Holding History

Independent Financial Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Hold
23,250
– – 0.01% 1173
2026
Q1 		$98.3K Hold
23,250
– – ﹤0.01% 1423
2025
Q4 		$87.7K Hold
23,250
– – ﹤0.01% 1386
2025
Q3 		$37.4K Hold
23,250
– – ﹤0.01% 1350
2025
Q2 		$50.9K Hold
23,250
– – ﹤0.01% 1276
2025
Q1 		$25.1K Hold
23,250
– – ﹤0.01% 1164
2024
Q4 		$24.2K Hold
23,250
– – ﹤0.01% 1150
2024
Q3 		$29.1K Hold
23,250
– – ﹤0.01% 1118
2024
Q2 		$27.7K Buy
23,250
+3,000
+15% +$4.08K ﹤0.01% 1076
2024
Q1 		$20.5K Hold
20,250
– – ﹤0.01% 1009
2023
Q4 		$21.5K Buy
20,250
+4,600
+29% +$4.98K ﹤0.01% 942
2023
Q3 		$25.7K Buy
15,650
+3,000
+24% +$4.73K ﹤0.01% 890
2023
Q2 		$19.9K Buy
+12,650
New +$20.3K ﹤0.01% 870

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Independent Financial Group's SLS Position: Q2 2026 in Review

Independent Financial Group held its SELLAS Life Sciences (SLS) position steady in Q2 2026 at 23,250 shares worth $343K. The position accounts for 0.01% of the portfolio, ranked #1173.

Independent Financial Group first reported a position in SLS in Q2 2023 and has held it in 13 quarters since. 192 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Independent Financial Group held 23,250 shares of SELLAS Life Sciences worth $343K as of Q2 2026.
  • Independent Financial Group left its SELLAS Life Sciences share count unchanged in Q2 2026.
  • SELLAS Life Sciences made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #1173 holding.
  • Independent Financial Group first reported a position in SELLAS Life Sciences in Q2 2023 and has held it in 13 quarters since.
  • 192 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.